Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:59 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Specific Phobia, Social Anxiety Disorder, Autism Spectrum Disorder
Interventions: Virtual Reality for Youth Phobias; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 8 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Oppositional Defiant Disorder, Conduct Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Booster Treatment, No-Booster, No intervention, Treatment As Usual; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 6 Years to 11 Years
Enrollment: 254 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2009
U.S. locations: 2
States / cities: Cincinnati, Ohio • Pittsburgh, Pennsylvania

Conditions: Autism Spectrum Disorder
Interventions: HEARTS classes, Online discussion group; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ADHD, Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder, ADD, ADHD Predominantly Inattentive Type, ADHD - Combined Type, ADHD, Predominantly Hyperactive - Impulsive, Attention-Deficit Disorder in Adolescence, Attention-Deficit Hyperactivity Disorder Symptoms, Attention-Deficit Hyperactivity Disorder
Interventions: Homework Organization and Planning Skills (HOPS) Intervention, Digital Health Application (Online Platform) for Encouraging Skills Practice; Behavioral · Device
Lead sponsor: Children's National Research Institute; Other
Eligibility: 11 Years to 14 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Autism Spectrum Disorder
Interventions: Anatomical MRI Scan; Diagnostic Test
Lead sponsor: San Diego State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Physician training; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 6 Years to 11 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Not listed
Lead sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD); NIH
Eligibility: 6 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: OPDC-34712, Placebo, Stimulant Therapy; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 740 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 35
States / cities: Little Rock, Arkansas • Beverly Hills, California • Irvine, California + 32 more

Conditions: ADHD, Attention Difficulties, Mood, Anxiety, Caffeine
Interventions: Proper Wild energy shot; Other
Lead sponsor: Proper Wild, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Autism Spectrum Disorder
Interventions: Function-Based Elopement Treatment (FBET), Parent Education Program (PEP); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 4 Years to 12 Years
Enrollment: 76 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Depression, Attention Deficit Disorder With Hyperactivity
Interventions: Integrated Parent Training, Behavioral Parent Training; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 6 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: College Park, Maryland

Conditions: Attention Deficit/Hyperactivity Disorder, ADHD
Interventions: L-Threonic Acid Magnesium Salt (L-TAMS); Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Autism, Enuresis, Incontinence
Interventions: Wireless Moisture Pager (WMP); Device
Lead sponsor: University of Rochester; Other
Eligibility: 3 Years to 6 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 3
States / cities: Rochester, New York • Columbus, Ohio • Nashville, Tennessee

Conditions: Autism, Autism Spectrum Disorder, Autism, Susceptibility to, 6
Interventions: Milieu Teaching-AV, Milieu Teaching-NoAV; Behavioral
Lead sponsor: Father Flanagan's Boys' Home; Other
Eligibility: 5 Months to 13 Months
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Autism Spectrum Disorder, Emotion Regulation
Interventions: Regulating Together-Canine, Regulating Together-Standard; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 8 Years to 15 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive
Interventions: N-acetylcysteine, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 4 Years to 12 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: ADHD
Interventions: Lidocaine gel; Drug
Lead sponsor: PhenoSolve, LLC; Industry
Eligibility: 7 Years to 49 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Voorhees Township, New Jersey

Conditions: Attention Deficit Disorder With Hyperactivity, HIV Infections, Paralysis
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: Not listed
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1995 – 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Valproate, Risperidone, Placebo, Stimulant medication, Behavioral family counseling; Drug · Behavioral
Lead sponsor: Joseph Blader; NIH
Eligibility: 6 Years to 12 Years
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 3
States / cities: Glen Oaks, New York • Stony Brook, New York • San Antonio, Texas

Conditions: Tourette Syndrome
Interventions: EPI-743; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Methylphenidate Transdermal System; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 25 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Meta Quest 3 VR Headset with noise cancelling headphones; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 25 Years
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Baton Rouge, Louisiana • New Brunswick, New Jersey

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: L-methylfolate, OROS-Methylphenidate, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: ADHD, Autism
Interventions: Observation; Other
Lead sponsor: MaxisHealth; Industry
Eligibility: 4 Years to 7 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Brooklyn, New York

Search by objective public record fields.

Virtual Reality for Youth Phobias

Resources to Enhance the Adjustment of Children (REACH)

HEARTS R34 Feasibility Study, Autistic Participants

Technology-Enhanced Executive Functioning Intervention for ADHD

Age-related Changes in Myeloarchitectonics Across Adulthood in Autism Spectrum Disorder

Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings

Studies of Measures of Attention

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

A Clinical Trial to Assess the Efficacy of a Plant-based Energy Shot on Focus and ADHD-like Symptoms

Structured Function-Based Elopement Treatment Program

Integrated Parent Training for Treating Depression in Mothers of Children With Attention Deficit Hyperactivity Disorder

L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD

Development of a Manualized Wireless Moisture Pager Intervention for Teaching Toileting in Children With Autism

Milieu Teaching-AV: Adaptation of Milieu Teaching That Encourages Looking to the Mouth

Evaluating Additive Effects of Including Canines in Regulating Together

A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders

Observational Study to Assess the Frequency of Lidocaine Ineffectiveness in Hard-to-treat ADHD

Assessment of Attentional Functioning in Children With HIV-1 Infection

Effectiveness of Combined Medication Treatment for Aggression in Children With Attention Deficit With Hyperactivity Disorder (The SPICY Study)

Open-Trial of EPI-743 for Adults With Tourette Syndrome

Enhancing ADHD Driving Performance With Stimulant Medication

R61/33 - VR Study Phase 4

L-methylfolate Supplementation to OROS-Methylphenidate Pharmacotherapy in ADHD Adults

Acceptability, Feasibility, and Development of an AI Driven, Multi-sensor, Non-invasive Digital Mental Health Platform in Children With ADHD and Emotional Symptoms